文献速递血栓与止血

抗凝血酶活性与高危出血危重患儿中心静脉导管相关血栓形成

Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding.
PubMed 文献 · J Thromb Haemost · 2023-10-04

导管置入日平均抗凝血酶婴儿为64 IU/dL、年长儿为83 IU/dL,至拔管日恢复正常。27例发生血栓、31例出血,抗凝血酶与血栓形成及出血均无关联,体外补充抗凝血酶可降低内源性凝血酶生成潜力。

要点

  • 导管置入日平均抗凝血酶婴儿64 IU/dL、年长儿83 IU/dL,拔管日恢复正常。
  • 27例发生导管相关血栓、31例出血,抗凝血酶与两者均无关联。
  • 体外补充抗凝血酶降低内源性凝血酶生成潜力(相关系数-0.78)。

核心结论

  • 这些发现可能不支持通过使抗凝血酶活性正常化来预防高危出血危重患儿的导管相关血栓形成。

研究设计与样本

  • 前瞻性队列研究,纳入年龄<18岁、高危出血并置入中心静脉导管的危重患儿。
  • 共纳入8例婴儿(中位年龄0.2岁,IQR 0.2、0.3岁)和72例年长儿(中位年龄14.3岁,IQR 9.1、16.1岁)。
  • 从乏血小板血浆及体外补充抗凝血酶后测定抗凝血酶活性与凝血酶生成,并以系统超声监测诊断血栓,随访出血。

主要发现

  • 导管置入日平均抗凝血酶婴儿为64 IU/dL(SD 32 IU/dL),年长儿为83 IU/dL(SD 35 IU/dL),至拔管日恢复正常。
  • 27例发生血栓形成,31例发生出血。
  • 血栓形成与抗凝血酶的回归系数为0.008(95%CI -0.01、0.03),出血与抗凝血酶的回归系数为-0.0007(95%CI -0.02、0.02),均无关联。
  • 抗凝血酶与体内内源性凝血酶生成潜力变化不相关(相关系数-0.07,95%CI -0.21、0.08)。
  • 体外补充抗凝血酶降低内源性凝血酶生成潜力(相关系数-0.78,95%CI -0.95、-0.23)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Normalization of antithrombin activity may prevent catheter-associated thrombosis in critically ill children at high risk of bleeding. OBJECTIVES: To characterize the temporal pattern of antithrombin activity, assess its association with catheter-associated thrombosis and clinically relevant bleeding, and evaluate its relationship with thrombin generation in these children. METHODS: In this prospective cohort study, critically ill children <18 years old at high risk of bleeding with central venous catheter were eligible. Antithrombin activity and thrombin generation were measured from platelet-poor plasma and after in vitro antithrombin supplementation. Systematic surveillance ultrasound was performed to diagnose thrombosis. Children were followed for bleeding. RESULTS: We enrolled 8 infants (median age: 0.2 years, IQR: 0.2, 0.3 years) and 72 older children (median age: 14.3 years, IQR: 9.1, 16.1 years). Mean antithrombin on the day of catheter insertion was 64 IU/dL (SD: 32 IU/dL) in infants and 83 IU/dL (SD: 35 IU/dL) in older children. Antithrombin normalized by the day of catheter removal. Thrombosis developed in 27 children, while 31 children bled. Thrombosis (regression coefficient: 0.008, 95% CI: -0.01, 0.03) and bleeding (regression coefficient: -0.0007, 95% CI: -0.02, 0.02) were not associated with antithrombin. Antithrombin was not correlated with in vivo change in endogenous thrombin potential (correlation coefficient: -0.07, 95% CI: -0.21, 0.08). In vitro supplementation reduced endogenous thrombin potential (correlation coefficient: -0.78; 95% CI: -0.95, -0.23). CONCLUSION: These findings may not support normalization of antithrombin activity to prevent catheter-associated thrombosis in critically ill children at high risk of bleeding.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Quinn T, Cholette JM, Pinto MG, et al. Antithrombin activity and central venous catheter-associated thrombosis in critically ill children at high risk of bleeding. J Thromb Haemost. 2023. PMID: 37797693. doi:10.1016/j.jtha.2023.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。